| Literature DB >> 24848522 |
Fan Qu1, Dan Zhang1, Lu-Ting Chen2, Fang-Fang Wang3, Jie-Xue Pan2, Yi-Min Zhu3, Chun-Mei Ma2, Yi-Ting Huang2, Xiao-Qun Ye2, Sai-Jun Sun2, Wen-Jun Zheng2, Run-Ju Zhang3, Jian Xu3, Lan-Feng Xing3, He-Feng Huang3.
Abstract
The study was to explore whether auricular acupressure (AA) can relieve anxiety during the period from trans-vaginal oocyte retrieval to the embryo transfer in IVF treatment and whether AA can improve the outcomes of IVF. 305 infertile patients with tubal blockage who were referred for IVF were included. The women were randomized into a control group with 102 cases, a Sham-AA group with 102 cases and an AA group with 101 cases. The anxiety levels were rated with Spielberger's State Trait Anxiety Inventory and the Amsterdam Preoperative Anxiety and Information Scale. Data of clinical pregnancy rate (CPR), implantation rate (IR) and live birth rate (LBR) were obtained. The levels of neuropeptide Y (NPY) and transforming growth factor alpha (TGF-alpha) in the follicular fluids were detected with ELISA. After treatment, in AA group, the levels of state anxiety, preoperative anxiety and need-for-information were significantly lower, whereas CPR, IR, LBR and NPY levels in the follicular fluids were markedly higher than Sham-AA group and control group. We concluded that AA could help to reduce anxiety levels associated with IVF and improves the outcomes of IVF partly through increasing the levels of NPY in the follicular fluids.Entities:
Mesh:
Year: 2014 PMID: 24848522 PMCID: PMC4030259 DOI: 10.1038/srep05028
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
The baseline characteristics of the participants
| Control | Sham AA | AA | |
|---|---|---|---|
| Items | (n = 102) | (n = 102) | (n = 101) |
| Ages (years) | 30.95 ± 4.78 | 30.87 ± 4.12 | 31.65 ± 4.30 |
| BMI (kg/m2) | 23.87 ± 6.14 | 21.01 ± 4.25 | 22.08 ± 3.55 |
| Duration of infertility (year) | 4.97 ± 4.17 | 4.16 ± 3.21 | 5.19 ± 3.39 |
| Day-3 LH | 5.17 ± 2.64 | 4.74 ± 2.55 | 5.01 ± 2.84 |
| Day-3 FSH (nmol/L) | 6.13 ± 2.45 | 6.89 ± 2.03 | 6.80 ± 2.42 |
| Day-3 TT(pmol/L) | 1.45 ± 0.14 | 1.31 ± 0.07 | 1.20 ± 0.02 |
| Day-3 E2(pmol/L) | 141.18 ± 68.02 | 149.27 ± 59.96 | 135.89 ± 70.92 |
| Cycle length (days) | 32.90 ± 9.02 | 33.09 ± 8.97 | 32.72 ± 7.99 |
| rFSH administered (IU) | 2245.18 ± 600.97 | 2090.75 ± 644.29 | 2117.32 ± 849.71 |
| Induction length (days) | 9.61 ± 1.87 | 9.98 ± 2.08 | 9.78 ± 2.06 |
| Number of oocytes | 14.80 ± 7.45 | 15.19 ± 6.89 | 14.97 ± 6.31 |
| Number of follicles >14 mm | 11.59 ± 6.50 | 12.42 ± 6.72 | 12.15 ± 4.98 |
| Fertilization rate | 1078/1510 (71.39%) | 1092/1549 (70.50%) | 1090/1512 (72.09%) |
| Embryo cleavage rate | 1052/1078 (97.59%) | 1059/1092 (96.98%) | 1054/1090 (96.70%) |
| Good-quality embryo rate | 719/1078 (66.70%) | 742/1092 (67.95%) | 718/1090 (65.87%) |
| Embryos transferred per cycle | 2.08 ± 0.66 | 2.04 ± 0.63 | 1.98 ± 0.54 |
| Education level | |||
| High | 26/102 (25.49%) | 29/102 (28.43%) | 27/101 (26.73%) |
| Medium | 32/102 (31.37%) | 33/102 (32.35%) | 30/101 (29.70%) |
| Low | 44/102 (43.14%) | 40/102 (39.22%) | 44/101 (43.56%) |
| Living Area | |||
| City | 62/102 (61.39%) | 61/102(59.80%) | 59/101 (58.42%) |
| Urban | 4/102 (3.92%) | 5/102 (4.90%) | 4/101 (3.96%) |
| Country | 36/102 (35.29%) | 36/102(35.29%) | 38/101 (37.62%) |
| Employment Type | |||
| Full-time | 56/102 (54.90%) | 53/102 (51.96%) | 54/101 (53.47%) |
| Part-time | 13/102 (12.75%) | 16/102 (15.69%) | 16/101 (15.84%) |
| Non-employment | 33/102 (32.35%) | 33/102 (32.35%) | 31/101 (30.69%) |
Note: Data were shown as mean ± S.D. *P<0.05, compared with the Control group; #P<0.05 compared with Sham AA group (For Chi-Square tests among three groups, the adjusted significance level for each comparison was set at P = 0.017(0.05/3) to give a significance level of 0.05 over all three tests: *P<0.017, compared with the Control group; #P<0.017 compared with Sham AA group). AA: auricular acupressure; BMI: body mass index; Day-3: the 3rd day of spontaneous menstrual cycle; LH: luteinizing hormone; FSH: follicle stimulating hormone; TT: total testosterone; E2: estradiol; r-FSH: recombinant FSH.
The levels of state anxiety, preoperative anxiety and need-for-information at T1 and T2, and the IVF outcomes
| Control | Sham AA | AA | |
|---|---|---|---|
| Items | (n = 102) | (n = 102) | (n = 101) |
| STAI (T1) | |||
| State anxiety | 42.91 ± 9.70 | 43.12 ± 8.01 | 44.01 ± 8.93 |
| APAIS (T1) | |||
| Anesthesia related anxiety | 3.51 ± 1.42 | 3.39 ± 1.39 | 3.59 ± 1.33 |
| Surgery related anxiety | 3.99 ± 1.21 | 3.81 ± 1.36 | 4.06 ± 1.36 |
| Need-for- information | 5.32 ± 1.54 | 5.25 ± 1.12 | 5.20 ± 1.51 |
| STAI (T2) | |||
| State anxiety | 41.11 ± 9.96 | 42.29 ± 9.55 | 34.79 ± 14.01 * # |
| APAIS (T2) | |||
| Anesthesia related anxiety | 3.12 ± 1.12 | 2.91 ± 1.07 | 1.97 ± 0.81 * # |
| Surgery related anxiety | 3.87 ± 1.21 | 3.56 ± 1.52 | 2.72 ± 1.17 * # |
| Need-for- information | 5.01 ± 1.62 | 4.71 ± 1.23 * | 4.03 ± 1.76 * # |
| Clinical pregnancy rate (%) | 40/102 (39.21%) | 41/102 (40.20%) | 59/101 (58.42%) * # |
| Implantation rate (%) | 51/202 (25.25%) | 52/206 (25.24%) | 78/211 (36.97%) * # |
| Live birth rate (%) | 31/102 (30.39%) | 32/102 (31.37%) | 53/101 (52.48%) * # |
Note: Data were shown as mean ± S.D. *P<0.05, compared with the Control group; #P<0.05 compared with Sham AA group. (For Chi-Square tests among three groups, the adjusted significance level for each comparison was set at P = 0.017(0.05/3) to give a significance level of 0.05 over all three tests: *P<0.017, compared with the Control group; #P<0.017 compared with Sham AA group). AA: auricular acupressure; T1: the time-point on the morning of one day before trans-vaginal oocyte retrieval; T2: the time-point on the morning of the day of embryo transfer; STAI: state trait anxiety inventory; APAIS: Amsterdam preoperative anxiety and information scale.
Figure 1(A) Neuropeptide Y (NPY) levels in follicular fluids of auricular acupressure (AA) group, Sham-AA group and control group. (B) Transforming growth factor alpha (TGF-alpha) levels in follicular fluids of AA group, Sham-AA group and control group. For all panels, results were expressed as mean ± S.D. *P<0.05 (ANOVA).
Figure 2The flow chart of the progress of participants through the trial.
The subjects of auricular acupressure (AA) group and Sham-AA group were asked to press the acupoints four times a day (08:00, 12:00, 16:00 and 20:00 h respectively) with 15 min each time by themselves. The AA treatment consisted of six days (from 12:00 h of one day before trans-vaginal oocyte retrieval to 20:00 h of the next day of embryo transfer) and was conducted on the two ears simultaneously.
Figure 3The auricular acupoints selected.
Shenmen (TF4, located at the bifurcation of the crura of antihelix), Endocrine (CO18, located at the bottom part of the incisura intertragica), and Internal Genitals (TF2, located at the middle point of anterior portion of the triangular fossa) were selected in auricular acupressure (AA) group; Triple Energizer (CO17, located in the cavum conchae), Stomach (CO4, located at the commissure of superior concha and inferio concha, just below the disappearance of the crus of the helix) and Large Intestine (CO7, located at the inner 1/3 of the crus of the helix, lying at the lower portion of the superior concha) were selected in Sham-AA group.